Opus, Viatris say presbyopia drug succeeds in Phase 3
Article Title: Opus, Viatris say presbyopia drug succeeds in Phase 3 Publication Date: June 26, 2025 A major development has emerged in the biotech industry as Opus Genetics and Viatris announce the successful results from the Phase 3 study of…